๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of lonidamine in metastatic prostatic carcinoma

โœ Scribed by David J. Stewart; Susan E. Aitken; Allen H. Irvine; David E. Moors; Norman G. Futter

Publisher
Springer US
Year
1991
Tongue
English
Weight
132 KB
Volume
9
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of tamoxifen in metastati
Phase II trial of tamoxifen in metastatic carcinoma of the prostate
โœ John H. Glick; Alan Wein; Kristin Padavic; William Negendank; David Harris; Harv ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 551 KB

Fifty-one patients with advanced metastatic carcinoma of the prostate were treated with the antiestrogen tamoxifen. Thirty-eight of these patients were refractory to prior hormonal manipulation with estrogens and/or orchiectomy, and five (13%) achieved an objective response (partial regression or st

Oral estramustine and cyclophosphamide i
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma : A phase II study
โœ Sergio Bracarda; Maurizio Tonato; Paolo Rosi; Verena De Angelis; Ettore Mearini; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

## BACKGROUND. Nearly all cases of metastatic prostate carcinoma progress, after hormonal ablation, to a hormone refractory status. To the authors' knowledge no standard chemotherapy for patients with hormone refractory prostate carcinoma (HRPC) exists. In a prospective study, the efficacy and toxi